Cargando…

Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer

BACKGROUND: In lung cancer, uPA, its receptor (uPAR), and the inhibitors PAI-1 and PAI-2 of the plasminogen activator family interact with MMP-2 and MMP-9 of the MMP family to promote cancer progression. However, it remains undetermined which of these markers plays the most important role and may be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Chia-Yi, Liu, Yu-Peng, Yang, Chih-Jen, Lin, Yuan-Feng, Chiou, Jean, Chi, Li-Hsing, Lee, Jih-Jong, Wu, Alex T. H., Lu, Pei-Jung, Huang, Ming-Shyan, Hsiao, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521958/ https://www.ncbi.nlm.nih.gov/pubmed/26230665 http://dx.doi.org/10.1371/journal.pone.0133411

Ejemplares similares

The opposite prognostic effect of NDUFS1 and NDUFS8 in lung cancer reflects the oncojanus role of mitochondrial complex I
por: Su, Chia-Yi, et al.
Publicado: (2016)

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
Publicado: (1990)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis
por: Chiou, Jean, et al.
Publicado: (2019)

Histone Deacetylase Inhibitor Impairs Plasminogen Activator Inhibitor-1 Expression via Inhibiting TNF-α-Activated MAPK/AP-1 Signaling Cascade
por: Chen, Wei-Lin, et al.
Publicado: (2014)

Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma
por: Chiou, Jean, et al.
Publicado: (2017)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)

Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients
por: Gurbuz, Yunus, et al.
Publicado: (2015)

Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome
por: Wygrecka, Malgorzata, et al.
Publicado: (2007)

Involvement of the Serine Protease Inhibitor, SERPINE2, and the Urokinase Plasminogen Activator in Cumulus Expansion and Oocyte Maturation
por: Lu, Chung-Hao, et al.
Publicado: (2013)

bFGF stimulated plasminogen activation factors, but inhibited alkaline phosphatase and SPARC in stem cells from apical Papilla: Involvement of MEK/ERK, TAK1 and p38 signaling
por: Chang, Mei-Chi, et al.
Publicado: (2021)

A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma
por: Jan, Yi-Hua, et al.
Publicado: (2019)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
por: Liu, Wen-Jing, et al.
Publicado: (2018)

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
por: Witzel, Isabell, et al.
Publicado: (2014)

Reduction of Canine Plasminogen Leads to an Expanded Molecule which Precipitates
por: Kornblatt, Jack A.
Publicado: (2009)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases
por: Wang, Qingcai, et al.
Publicado: (2003)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

A Novel Serine Protease Secreted by Medicinal Maggots Enhances Plasminogen Activator-Induced Fibrinolysis
por: van der Plas, Mariena J. A., et al.
Publicado: (2014)

Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction
por: Askari, Arman T., et al.
Publicado: (2003)

Validating plasminogen activator inhibitor‐1 as a poor prognostic factor in sepsis
por: Hoshino, Kota, et al.
Publicado: (2020)

Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness
por: Chang, Yu-Chan, et al.
Publicado: (2020)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
por: Lampelj, Maja, et al.
Publicado: (2015)

A Novel Role for Plasminogen Activator Inhibitor Type-2 as a Hypochlorite-Resistant Serine Protease Inhibitor and Holdase Chaperone
por: Cater, Jordan H., et al.
Publicado: (2022)

Cerebral desaturation in heart failure: Potential prognostic value and physiologic basis
por: Chen, Yu-Jen, et al.
Publicado: (2018)

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies
por: Bajou, Khalid, et al.
Publicado: (2001)

Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis.
por: Yoshino, H., et al.
Publicado: (1998)

The lysosomal cathepsin protease CPL-1 plays a leading role in phagosomal degradation of apoptotic cells in Caenorhabditis elegans
por: Xu, Meng, et al.
Publicado: (2014)

Plasminogen
por: Kline, Daniel L.
Publicado: (1954)

Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer
por: Leissner, Philippe, et al.
Publicado: (2006)

Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells
Publicado: (1976)

Correction: A Novel Serine Protease Secreted by Medicinal Maggots Enhances Plasminogen Activator-Induced Fibrinolysis
Publicado: (2014)

Pollen Proteases Play Multiple Roles in Allergic Disorders
por: Gaspar, Ricardo, et al.
Publicado: (2020)

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
por: Nakatsuka, Erika, et al.
Publicado: (2017)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer
por: Abbink, Karin, et al.
Publicado: (2020)

Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10
por: Madureira, Patricia A., et al.
Publicado: (2016)

Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle
por: Chen, Jyh-Ping, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vcb9l0adrvbmprspdi1sh6hftm